The purpose of this study is to investigate the effects of a treatment for pancreatic cancer. This study investigates the use of HRS-4642 in combination with chemotherapy medicines for patients diagnosed with this condition.
This study evaluates the safety and effectiveness of the investigational treatment. Researchers will assess how well patients tolerate the medicine and its impact on the condition.
- Who can participate: Adults aged 18 to 80 with ductal adenocarcinoma of the pancreas can participate. Participants must have a measurable lesion and meet specific health criteria.
- Study details: Participants will receive an investigational medication along with chemotherapy.